Physician profile
Mark Bonnell
NPI 1215123450
$140,779.48
in general payments reported to CMS, 2019-2025
20 companies · $41K in 2025
The $41K reported for 2025 was more than what 97% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,070 · 2020: $6,951 · 2021: $11K · 2023: $32K · 2024: $45K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $116K · Food and Beverage: $1,928 · Entertainment: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $116,163.00 |
| Food and Beverage | $1,928.48 |
| Entertainment | $113.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $116,627.33 | 2023-2025 | Sternalock, Sternalock 360 System, Cable-Ready |
| Jace Medical LLC | $21,134.11 | 2019-2021 | |
| Abiomed | $1,011.28 | 2020-2025 | Impella |
| Abbott Laboratories | $593.77 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $198.31 | 2020-2024 | Lifevest |
| Bolton Medical INC | $146.13 | 2021 | |
| Medtronic, INC. | $141.31 | 2021-2024 | Corevalve Evolut R |
| Kls-Martin L.P. | $133.80 | 2024 | |
| Angiodynamics, INC. | $126.00 | 2021 | |
| Cook Medical LLC | $125.00 | 2020 | |
| Argentum Medical | $113.58 | 2024 | |
| Atricure, INC. | $109.27 | 2024-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Edwards Lifesciences Corporation | $92.51 | 2024-2025 | Mitris Resilia Mitral Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Vapotherm INC | $64.34 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $54.53 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.80 | 2021 | |
| Medtronic Vascular, INC. | $26.10 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $21.04 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.28 | 2019 | |
| Artivion, INC. | $14.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bonnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.